Twist Bioscience (TWST) Accumulated Expenses (2018 - 2026)

Twist Bioscience (TWST) has reported Accumulated Expenses for 9 consecutive years, with $34.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accumulated Expenses rose 20.39% year-over-year to $34.9 million in Q2 2026; TTM through Jun 2026 was $34.9 million, a 20.39% increase from a year earlier, with the FY2025 full-year figure at $31.3 million, down 7.02% from the prior year.
• Accumulated Expenses was $34.9 million for Q2 2026 at Twist Bioscience, up from $27.0 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $34.9 million in Q2 2026 and troughed at $20.8 million in Q4 2023.
• A 5-year average of $26.7 million and a median of $26.4 million in 2023 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses jumped 45.57% in 2022 and decreased 10.7% in 2023, its largest moves.
• Over 5 years, Accumulated Expenses stood at $23.3 million in 2022, then declined by 10.7% to $20.8 million in 2023, then increased by 4.59% to $21.7 million in 2024, then grew by 7.65% to $23.4 million in 2025, then soared by 49.02% to $34.9 million in 2026.
• The last three Accumulated Expenses figures came in at $34.9 million (Q2 2026), $27.0 million (Q1 2026), and $23.4 million (Q4 2025), per Business Quant data.